EPR spin trapping and 2-deoxyribose degradation studies of the effect of pyridoxal isonicotinoyl hydrazone (PIH) on ·OH formation by the Fenton reaction

Biochimica et Biophysica Acta - General Subjects

Volumn 1426, Issue 3, 1999, Pages 475-482

  Hermes Lima, Marcelo ^a   Santos, Natacha C F ^a   Yan, Junguo ^b   Andrews, Mark ^b   Schulman, Herbert M ^c,d   Ponka, Prem ^c  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d BioMed Consult and Edit Services   (Canada)

Author keywords

Electron paramagnetic resonance; Fenton reaction; Free radical; Iron; Pyridoxal isonicotinoyl hydrazone; Salicylaldehyde isonicotinoyl hydrazone

Indexed keywords

DEFEROXAMINE MESYLATE; EDETIC ACID; FREE RADICAL; OXYGEN RADICAL; PYRIDOXAL ISONICOTINOYLHYDRAZONE; SALICYLALDEHYDE ISONICOTINOYLHYDRAZONE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL REACTION; ELECTRON SPIN RESONANCE; HYDROXYLATION; IRON CHELATION; OXIDATION; PRIORITY JOURNAL;

EID: 0033057183     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(98)00167-6     Document Type: Article

References (25)

1. H.M. Schulman, M. Hermes-Lima, E.M. Wang, P. Ponka, In vitro antioxidant properties of the iron chelator pyridoxal isonicotinoyl hydrazone (PIH) and some of its analogs, Redox Rep. 1 (1995) 373-378.
2. M. Bhattacharya, P. Ponka, P. Hardy, N. Hanna, D.R. Varma, P. Lachapelle, S. Chemtob, Prevention of postasphyxia electroretinal dysfunction with a pyridoxal hydrazone, Free Radic. Biol. Med. 22 (1997) 11-16.
3. •OH-mediated strand breaks, Free Radic. Biol. Med. (1998) in press.
4. P. Ponka, J. Borova, J. Neuwirt, O. Fuchs, Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent, FEBS Lett. 97 (1979) 317-321.
5. G.M. Brittenham, Pyridoxal isonicotinoyl hydrazone. Effective iron chelation after oral administration, Ann. NY Acad. Sci. 612 (1990) 315-326.
6. P. Ponka, Physiology and pathophysiology of iron metabolism: implications for iron chelation therapy in iron overload, in: J.J.M. Bergeron, G.M. Brittenham (Eds.), The Development of Iron Chelators for Clinical Use, CRC Press, Boca Raton, FL, 1994, pp. 1-32.
7. D.R. Richardson, P. Ponka, Pyridoxal isonicotinoyl hydrazone and its analogues: potential orally effective iron chelating agents for the treatment of iron overload disease, J. Lab. Clin. Med. 131 (1998) 306-314.
8. C. Hershko, Iron chelators, in: J.H. Brock, J.W. Halliday, M.J. Pippard, L.W. Powell (Eds.), Iron Metabolism in Health and Disease, W.B. Saunders, London, 1994, pp. 391-426.
9. J. Webb, M.L. Vitolo, Pyridoxal isonicotinoyl hydrazone (PIH): a promising new iron chelator, Birth Defects Orig. Art. Ser. 23, (5B) (1998) 63-70.
10. D.R. Richardson, G.T. Hefter, P.M. May, J. Webb, E. Baker, Iron chelators of the pyridoxal isonicotinoyl hydrazone class III. Formation constants with calcium(II), magnesium(II) and zinc(II), Biol. Metals 2 (1989) 161-167.
11. G.R. Buettner, Spin trapping: ESP parameters of spin adducts, Free Radic. Biol. Med. 3 (1987) 259-303.
12. M. Hermes-Lima, E.M. Wang, H.M. Schulman, K.B. Storey, P. Ponka, Deoxyribose degradation catalyzed by Fe(III)EDTA: kinetic aspects and potential usefulness for submicromolar iron measurements, Mol. Cell. Biochem. 137 (1994) 65-73.
13. R.S. Britton, B.R. Bacon, A.S. Tavill, Mechanisms of iron toxicity, in: J.H. Brock, J.W. Halliday, M.J. Pippard, L.W. Powell (Eds.), Iron Metabolism in Health and Disease, W.B. Saunders, London, 1994, pp. 311-351.
14. E. Baker, D. Richardson, S. Gross, P. Ponka, Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture, Hepatology 15 (1992) 492-501.
15. S.P. Sanders, S.J. Harrison, P. Kuppusamy, J.T. Sylvester, J.L. Zweier, A comparative study of EPR spin trapping and cytochrome C reduction techniques for the measurement of superoxide anions, Free Radic. Biol. Med. 16 (1994) 753-761.
16. J. Jiang, J.F. Bank, C.P. Scholes, Subsecond time-resolved spin trapping followed by stopped-flow EPR of Fenton reaction products, J. Am. Chem. Soc. 115 (1993) 4742-4746.
17. L.A. Reinke, J.M. Rau, P.B. McCay, Characteristics of an oxidant formed during iron(II) autoxidation, Free Radic. Biol. Med. 16 (1994) 485-492.
18. N.C.F. Santos, Quantificação da Ação Antioxidante do Piridoxal Isonicotinoil Hidrazona (PIH) contra o Estresse Oxidativo Induzido por Íons Ferro, M.Sc. Thesis, University of Brasilia, Brasilia, 1998.
19. 2-reactive species in oxygen toxicity in biology, J. Biol. Chem. 23 (1990) 13589-13594.
20. L.M.W. Vitolo, G.T. Hefter, B.W. Clare, J. Webb, Iron chelators of the pyridoxal isonicotinoyl hydrazone class. Part 2. Formation constants with iron(III) and iron(II), Inorg. Chim. Acta 170 (1990) 171-174.
21. S.J. Klebanoff, A.M. Waltersdorph, B.R. Michel, H. Rosen, Oxygen-based free radical generation by ferrous ions and deferroxamine, J. Biol. Chem. 264 (1989) 19765-19771.
22. D.R. Richardson, M.L. Wis Vitolo, G.T. Hefter, P.M. May, B.W. Clare, J. Webb, P. Wilairat, Iron chelators of the pyridoxal isonicotinoyl hydrazone class. Part I. Ionization characteristics of the ligands and their relevance to biological properties, Inorg. Chim. Acta 170 (1990) 165-170.
23. Z.I. Cabantchik, H. Glickstein, P. Milgram, W. Breuer, A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells, Anal. Biochem. 233 (1996) 221-227.
24. R.S. Britton, Metal-induced hepatotoxicity, Semin. Liver Dis. 16 (1996) 3-12.
25. S.P.J. Brooks, A simple computer program with statistical tests for the analysis of enzymatic kinetics, Biotechniques 13 (1992) 906-911.